Eli Lilly's Orforglipron (Not Yet Approved - Expected March 2026): According to CNN, Eli Lilly's experimental oral drug showed 11% mean weight loss over 72 weeks on its highest dose in clinical trials
Plan ahead for moves: insulated container, ice packs, and refrigerator access at the destination
A different study (112) found that liraglutide markedly lessened cerebral infarction without causing hypoglycaemia in non-diabetic rats
Zheng J, Ding Y, Tian B, Wang ZL, Zhuang X: Luminescent and raman active silver nanoparticles with polycrystalline structure
According to NICE guidance, tirzepatide should be prescribed as part of a comprehensive treatment plan that includes dietary modification, increased physical activity, and ongoing clinical monitoring